Patents by Inventor Susan P. Perrine

Susan P. Perrine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions and methods using isobutyramide for treating betaglobin disorders
    Patent number: 5439939
    Abstract: This invention relates to treatment of betaglobin disorders, such as sickle-cell anemia and beta-thalassemia, by administering compositions of isobutyramide.
    Type: Grant
    Filed: March 17, 1992
    Date of Patent: August 8, 1995
    Assignee: Children's Hospital Medical Center of Northern California
    Inventor: Susan P. Perrine
  • Method for preventing malaria
    Patent number: 5216004
    Abstract: A method is provided for preventing malaria by administering to a subject an effective amount of activin, inhibin, an inhibin chain, a butyrate analog, or mixtures thereof, to inhibit the development of malarial parasites.
    Type: Grant
    Filed: September 13, 1990
    Date of Patent: June 1, 1993
    Assignee: Children's Hospital Medical Center of North California
    Inventor: Susan P. Perrine
  • Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin
    Patent number: 4997815
    Abstract: A method is provided for inhibiting the .gamma.-globin to .beta.-globin switching in subjects afflicted with .beta.-globin disorders. The method is particularly adapted for ameliorating the clinical symptoms of sickle cell disease or .beta.-thalassemias by periodically introducing into the subject prio r to natural completion of the switching process activin, inhibin, an inhibin chain or mixtures thereof.
    Type: Grant
    Filed: November 1, 1988
    Date of Patent: March 5, 1991
    Assignees: Children's Hospital Medical Center of Northern California, Regents of the University of California
    Inventors: Susan P. Perrine, Norbert Albers
  • Method for augmenting fetal hemoglobin
    Patent number: RE36080
    Abstract: A method is provided for inhibiting the .gamma. to .beta.-globin switching in subjects afflicted with .beta.-globin disorders. The method is particularly adapted for ameliorating the clinical symptoms of sickle cell anemia by periodically introducing butyrate, .Iadd..alpha.-amino-n-butyric acid, .Iaddend.or .?.certain isomers, homologs, analogs or chemical variations thereof,.!. .Iadd.isobutyramide .Iaddend.into the bloodstream of the subject prior to natural completion of the switching process.
    Type: Grant
    Filed: June 18, 1993
    Date of Patent: February 2, 1999
    Assignee: Children's Hospital Medical Center of Northern California
    Inventor: Susan P. Perrine